Site icon Press Network of India

Fortis Bannerghatta Road, Introduces Dedicated ILD and Lung Failure Clinic for Evaluation and Management of Progressive Lung Diseases

Bengaluru : Fortis Hospital, Bannerghatta Road, has introduced a dedicated Interstitial Lung Disease (ILD) and Lung Failure Clinic to facilitate the evaluation and management of patients with progressive lung diseases. Led by Dr. Srivatsa Lokeshwaran, Director of Interventional Pulmonology and Lung Transplantation, Fortis Hospitals, Bengaluru, the clinic will facilitate coordinated clinical assessment and management through a multidisciplinary approach involving ILD pulmonology, thoracic radiology, rheumatology, pathology, transplant medicine and surgery, rehabilitation, nutrition and supportive care.

Interstitial Lung Disease (ILD) comprises a group of conditions that cause inflammation and scarring of the lung tissue, potentially affecting lung function and breathing. For patients with progressive lung diseases, timely diagnosis, regular monitoring and appropriate treatment are important in managing the condition and assessing disease progression. The clinic will support patients through individualised treatment planning, rehabilitation, long-term disease management and regular clinical assessment, enabling the treating team to evaluate disease progression and determine the appropriate course of care.

A key focus of the clinic will be the assessment of patients who may require lung transplantation, allowing evaluation to be initiated at an appropriate stage of the disease. Regular assessment of symptoms, lung function, exercise capacity, oxygen requirements and imaging can help the treating team monitor disease progression and determine when further transplant evaluation may be appropriate. Early assessment also allows patients to undergo clinical evaluation and preparation for transplantation, where required and medically indicated.

For carefully selected patients who develop severe respiratory deterioration, Extracorporeal Membrane Oxygenation (ECMO), a form of advanced life support that temporarily supports heart and lung function, may be considered as a bridge to transplantation, based on the patient’s clinical condition and the treating team’s assessment.

Commenting on the launch, Dr. Srivatsa Lokeshwaran, Director of Interventional Pulmonology and Lung Transplantation, Fortis Hospitals, Bengaluru, said, “Patients with progressive lung diseases may require different forms of clinical assessment and management depending on the nature and stage of their condition. The ILD and Lung Failure Clinic will facilitate multidisciplinary evaluation, regular monitoring of disease progression and individualised treatment planning. For patients who may require lung transplantation, early assessment can help determine their suitability and the appropriate timing for further evaluation. This also allows the treating team to assess their clinical condition and plan the next steps in management.”

Mr. Gautham C. B., Facility Director, Fortis Hospital, Bannerghatta Road, Bengaluru, said, “Progressive lung diseases often require ongoing medical evaluation and coordination across different specialities. The introduction of the ILD and Lung Failure Clinic reflects our focus on facilitating access to coordinated clinical services for patients with these conditions. Through this initiative, we aim to provide patients with a structured point of access for evaluation, monitoring and guidance on available treatment options, based on their clinical requirements.”

*****

Exit mobile version